DOI:
10.1055/s-00000071
Seminars in Neurology
LinksClose Window
References
Chiriboga CA, Swoboda KJ, Darras BT. , et al.
Results from a phase 1 study of nusinersen (ISIS-SMN(Rx)) in children with spinal muscular atrophy.
Neurology 2016;
86 (10) 890-897
We do not assume any responsibility for the contents of the web pages of other providers.